APA (7th ed.) Citation

Shiramoto, M., Yoshihara, T., Schmider, W., Takagi, H., Nowotny, I., Kajiwara, M., & Muto, H. (2021). Pharmacokinetic and pharmacodynamic similarity between SAR341402 insulin aspart and Japan-approved NovoRapid in healthy Japanese subjects. Nature Portfolio.

Chicago Style (17th ed.) Citation

Shiramoto, Masanari, Tatsuya Yoshihara, Wolfgang Schmider, Hiroki Takagi, Irene Nowotny, Miyuki Kajiwara, and Hideya Muto. Pharmacokinetic and Pharmacodynamic Similarity Between SAR341402 Insulin Aspart and Japan-approved NovoRapid in Healthy Japanese Subjects. Nature Portfolio, 2021.

MLA (8th ed.) Citation

Shiramoto, Masanari, et al. Pharmacokinetic and Pharmacodynamic Similarity Between SAR341402 Insulin Aspart and Japan-approved NovoRapid in Healthy Japanese Subjects. Nature Portfolio, 2021.